02858nam 2200853z- 450 991056645910332120231214133155.0(CKB)5680000000037790(oapen)https://directory.doabooks.org/handle/20.500.12854/81067(EXLCZ)99568000000003779020202205d2022 |y 0engurmn|---annantxtrdacontentcrdamediacrrdacarrierPharmacogenomicsFrom Basic Research to Clinical ImplementationBaselMDPI - Multidisciplinary Digital Publishing Institute20221 electronic resource (162 p.)3-0365-2835-0 3-0365-2834-2 This Special Issue focuses on the current state of pharmacogenomics (PGx) and the extensive translational process, including the identification of functionally important PGx variation; the characterization of PGx haplotypes and metabolizer statuses, their clinical interpretation, clinical decision support, and the incorporation of PGx into clinical care.Pharmacogenomics MedicinebicsscPharmacologybicsscpharmacogenomicsreturn of resultsgenetic counselingqualitativepharmacogeneticsimplementationpharmacogenetics servicescreeningpre-emptivepersonalized medicineprecision medicinecommunity pharmacypharmacogenomic testinggenetic privacypharmaco-economicspolymorphismspharmacogenespharmacogenomicmachine learningadaptationhuman evolutionUS Food and Drug Administrationclinical actionabilityclinical translationchronic kidney diseaseCYP3A5polymorphismprogressionpharmacogenomics (PGx)pediatricsbest practice alerts (BPAs)electronic health records (EHR)genomic indicatorsclinical decision support (CDS)phenotypegenotypepolypharmacychronic diseasemedication managementelectronic medical recordartificial intelligenceMedicinePharmacologyScheinfeldt Laura Bedt1299056Scheinfeldt Laura BothBOOK9910566459103321Pharmacogenomics3025009UNINA